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Abstract Arthrogryposis multiplex congenita (AMC) is a
heterogeneous condition defined as multiple congenital
joint contractures in two or more body areas. The common
pathogenesis is impaired fetal movements. Amyoplasia, the
most frequent form, is a sporadically occurring condition
with hypoplastic muscles and joint contractures. Distal
arthrogryposis (DA) syndromes are often hereditary, and
joint involvement is predominantly in the hands and feet.
In a Swedish study, 131 patients with arthrogryposis were
investigated. The most frequent diagnoses were amyoplasia
and DA. In amyoplasia, muscle strength was found to be
more important than joint range of motion (ROM) for
motor function. In DA, muscle weakness was present in
44 % of investigated patients. The clinical findings were
found to be highly variable between families and also
within families with DA. Fetal myopathy due to sarcomeric
protein dysfunction can cause DA. An early multidisci-
plinary team evaluation of the child with arthrogryposis for
specific diagnosis and planning of treatment is recom-
mended. Attention should be directed at the development
of muscle strength with early stimulation of active move-
ments. Immobilization should be minimized.
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Introduction
Arthrogryposis multiplex congenita (AMC) is defined as
congenital, non-progressive contractures in more than two
joints and in multiple body areas. The term ‘‘multiple
congenital contractures’’ may be used synonymously. The
diagnosis is purely descriptive, and arthrogryposis can be
present in at least 200 different syndromes [1]. The liter-
ature is confusing regarding types of arthrogryposis
described, as different diagnoses are often lumped together
and regarded as one entity.
The most frequently occurring form of arthrogryposis is
amyoplasia [1], a sporadically occurring condition some-
times referred to as ‘‘classical arthrogryposis’’. The second
most common form is probably distal arthrogryposis (DA)
[2, 3], a group of syndromes with mainly distal joint con-
tractures [1, 4].
Causes
Compromised fetal mobility is the main background factor,
common to all different types of arthrogryposis. The cause
can be pathology in the peripheral or central nervous sys-
tem (CNS), in muscles or in connective tissue, defects in
neuromuscular transmission, compromised space in utero,
maternal disease, external factors like medication or drugs,
or compromised vascular supply to the fetus [1].
It has been suggested that the joint fixations in multiple
congenital contractures are caused by a proliferation of
capsular connective tissue, a compensatory connective
tissue response to lack of movement in utero [5].
Pathologic changes in children with AMC were descri-
bed in a study by Banker in 1986 [6]. Abnormalities in the
neuromuscular system were found in all cases, with the
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primary alterations in anterior horn cells, roots, peripheral
nerves, motor end-plates, or muscles. All had onset during
fetal development.
Investigation of the spinal cord in infants with neuro-
genic arthrogryposis has demonstrated abnormal histology
and unequal distribution of alpha motor neurons in anterior
horn cells, the latter being also predictive of involved
muscle groups [7]. Several studies report that neurogenic
arthrogryposis (of the amyoplasia type) can be caused by
vascular compromise in early fetal development, with
ischemia of anterior horn cells leading to fetal akinesia and
poor or absent muscle development, but also, in some
cases, to co-existing anomalies with presumed vascular
genesis, i.e., gastroschisis, bowel atresia, Mo¨bius syn-
drome, and focal muscle defects [1, 8–10].
Arthrogryposis can be present in several congenital
myopathic disorders, e.g., nemaline myopathy [11], cen-
tronuclear myopathy [12], central core disease and others,
in congenital muscle dystrophies (Fukuyama, Ullrich) [1],
in severe SMA1 with fetal onset [13], and in severe con-
genital polyneuropathies [14–16].
Several DA syndromes have recently been discovered to be
caused by mutations in sarcomeric muscle proteins [17–20].
A number of collagen disorders can also appear with
arthrogryposis, for example Ehlers–Danlos syndrome [21],
Marfan syndrome [22], and Larsen syndrome. DA9, Beals
syndrome, has also been found to be a collagen disorder
with a mutation in the fibrillin FBN2 gene [23].
Disease affecting the neuromuscular junction with
resulting weakness can cause arthrogryposis. It has been
reported that congenital myasthenic syndrome with
arthrogryposis [24], congenital myotonic dystrophy [25],
and maternal antibodies to fetal neurotransmitters [26] can
all cause arthrogryposis.
Movement restriction in utero caused by, e.g., oligohy-
dramnios, myoma/fibroma of the uterus, and bicornate
uterus can be associated with arthrogryposis. Arthrogry-
posis of the amyoplasia type occurs with increased fre-
quency in one of monozygotic twins, but the cause in these
cases is thought to be more related to vascular compromise
than to actual crowding [8, 27].
A separate group of arthrogryposis syndromes are those
caused by maternal disease during pregnancy, such as
maternal multiple sclerosis, maternal myasthenia gravis,
maternal diabetes mellitus, and maternal hyperthermia [1].
Metabolic disease such as phosphofructokinase deficiency
can cause arthrogryposis, and drugs taken during preg-
nancy can also be associated with arthrogryposis (e.g.,
muscle relaxants, misoprostol, cocaine, alcohol) [1].
Contractures caused by compromised space in utero
have a relatively late gestational onset and are relatively
mild. These types of congenital contractures regress more
easily compared to contractures caused by early immobility
of the fetus [28].
Occurrence
In a retrospective epidemiologic study in western Sweden
by Darin et al., all children born with multiple congenital
contractures between 1979 and 1994 were identified
through screening of registers, reviews of medical records,
and re-examination of children. Sixty-eight cases were
identified, and the birth prevalence was found to be 1 in
5100 live births [29]. In this study, 39 patients had cerebral
or spinal involvement, three patients had mechanical
restriction in utero, 12 neuromuscular, and nine connective
tissue involvement.
Clinical classification
An approach to clinical evaluation that has been found to
be useful has been suggested and further developed by Hall
[1]. According to this, patients can be divided into three
main groups of disorders: (1) primarily musculoskeletal
involvement; (2) musculoskeletal involvement plus other
system anomalies; and (3) musculoskeletal involvement
plus CNS dysfunction and/or mental retardation (MR).
Amyoplasia or ‘‘classic arthrogryposis’’ belongs to the
first group, as do several camptodactyly syndromes, DA
type 1, popliteal pterygium syndrome, several sympha-
langism syndromes, and others.
In the second group, i.e., involvement of limbs and other
body areas, several other camptodactyly syndromes, sev-
eral DA syndromes, myotonic dystrophy, congenital
myopathies, myasthenia gravis, connective tissue disorders
such as Larsen syndrome, and Marfan syndrome with
congenital contractures are included.
The third group includes a great number of genetic
syndromes and chromosomal anomalies. Examples from
this group are cerebro-oculo-facio-skeletal (COFS) syn-
drome, congenital muscular dystrophy, Miller–Dieker
(lissencephaly), lethal multiple pterygium syndrome, Pena–
Shokeir phenotype, Potter syndrome, Zellweger syndrome,
trisomy 8/mosaicism, trisomy 18, and many others. This
group includes lethal syndromes and syndromes with sev-
ere disabilities due to CNS malfunction.
Mental retardation/CNS involvement is found in
approximately 25 % of individuals with AMC [1, 30].
Since there is a very large number of disorders with
arthrogryposis, differential diagnosis can be difficult. It is,
however, important to make as specific a diagnosis as
possible for several reasons:
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• Treatment can vary depending on the underlying cause
in the individual child. For example, stretching should
be minimized in diastrophic dysplasia, where too
intensive mobilization may damage joint cartilage.
The joint contractures can also be more resistant to
treatment in certain types of AMC, especially amy-
oplasia [31], and surgery and splinting may need to be
planned accordingly.
• Risk of re-occurrence varies greatly: amyoplasia occurs
sporadically, while several forms of DA have autoso-
mal dominant inheritance with a recurrence rate of
50 %.
• The prognosis is also very much dependent on diagno-
sis, where conditions with CNS involvement may have
a poor prognosis, sometimes with early death, while
other conditions have a normal lifespan but may need
extensive orthopedic treatment and rehabilitation.
Amyoplasia
The most common form of arthrogryposis is amyoplasia,
which accounts for approximately one-third of all cases [1].
The word ‘‘amyoplasia’’ means no muscle formation.
Amyoplasia occurs sporadically. Pathogenesis is unknown
but thought to be impaired blood circulation to the fetus
early in pregnancy, with hypotension and hypoxia dam-
aging the anterior horn cells and resulting in lack of or
underdevelopment of muscle tissue with fatty or connec-
tive tissue replacement [1, 32]. Clinically, the common
morphologic features suggest a genetic syndrome, but
occurrence is sporadic and individuals with amyoplasia
have unaffected children [1]. Amyoplasia occurs in
increased frequency in one of monozygotic twins [1].
The diagnostic criteria for amyoplasia are highly
specific, with decreased muscle mass, typical joint con-
tractures, and limb positioning at birth, mostly symmetrical
in all four limbs. There may be involvement only of the
lower limbs or, less commonly, only of the upper limbs and
asymmetric limb involvement [1, 33]. Typically, the
shoulders are adducted and internally rotated, and the
elbows are extended with the forearms pronated and wrists
and fingers flexed. The hips are either in abduction and
external rotation with flexed knees, or flexed with extended
or flexed knees. Hips and knees can be dislocated. The feet
are most often in an equinovarus adductus position,
although other types of foot deformities occur. Involve-
ment of the spine is also described [1, 33]. The contractures
can be fixed or flexible.
There is usually dimpling of the skin over affected
joints. Common associated findings are midline facial
hemangiomas and a round facial appearance. Muscle
defects in the abdominal wall and inguinal hernias occur in
about 10 % of children born with amyoplasia, and gas-
troschisis and bowel atresia have also been recorded [8].
Mental development is normal [33], unless there has been a
concomitant birth asphyxia or other additional problems.
Contractures in children with amyoplasia are at their
maximum at birth. To increase the joint range of motion
(ROM) and to obtain a functional position of the joint, a
combination of stretching, splinting, and orthopedic sur-
gery is often necessary [34–36]. Early physical therapy is
very important, both to mobilize joints and to stimulate
muscle growth and to prevent further muscular atrophy
[31]. In amyoplasia, the joint contractures can be severe
and have a tendency to recur after correction [36].
Distal arthrogryposis
DA syndromes are characterized by mainly distal con-
genital joint contractures, i.e., in the hands and feet. The
exact incidence of DA is not known. In a large study of
over 350 patients with arthrogryposis, 44 (12.6 %) patients
with DA were identified [1]. In another review, 35 % of
155 patients with arthrogryposis were diagnosed with DA
[3]. In an epidemiological survey from western Sweden, 5
(7 %) patients with DA syndromes were identified in a
total of 68 patients with multiple congenital contractures
[29].
DA has been defined as arthrogryposis with congenital
hand and foot involvement by Hall et al. in 1982 [1]: type I
with only distal joint involvement and characteristic hands
at birth with flexed and overlapping fingers, and type IIA–
IIE with distal limb contractures and additional character-
istic manifestations.
A revised and extended classification was made by
Bamshad et al. in 1996 [4]. In this classification, DA is
defined as an inherited primary limb malformation disorder
characterized by congenital contractures of two or more
different body areas and without primary neurological and/
or muscle disease that affects limb function. Included
disorders are characterized by distal joint involvement,
limited proximal joint involvement, autosomal dominant
inheritance, reduced penetrance, and variable expressivity.
In this classification, nine different clinical forms are
originally described, with a tenth syndrome defined in 2006
[4, 37].
The prevalence of DA syndromes is not known. The
most commonly described forms of DA are DA1 and
DA2B. DA1 is characterized by clenched fists at birth,
ulnar deviation, medially overlapping fingers, and club feet
or other foot malpositions. The hips may be affected,
calves small, and opening of the mouth mildly limited [38].
DA2B, Sheldon–Hall syndrome, is similar to but milder
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than DA2A [2, 39]. DA2A, Freeman–Sheldon syndrome, is
characterized by a small mouth, facial contractures, scol-
iosis, mainly distal joint contractures, and short stature
[39]. Typical findings in DA2B are vertical talus, ulnar
deviation, severe camptodactyly, triangularly shaped face,
prominent nasolabial folds, downslanting palpebral fis-
sures, small mouth, and prominent chin [2]. Foot defor-
mities may be asymmetric [40].
The sarcomere is the functional unit of striated muscle
contraction. Mutations in sarcomeric proteins are found in
at least 20 different skeletal muscle diseases [41] and can
result in DA or in congenital myopathy [12].
Mutations in genes encoding sarcomeric muscle proteins
are found in several DA syndromes: Sung et al. described
mutations in b tropomyosin (TPM2), in DA1, and muta-
tions in fast troponin I (TNNI2), and fast troponin T
(TNNT3) in DA2B [17]. Toydemir et al. describes muta-
tions in embryonic myosin heavy chain (MYH3) in DA2A,
Freeman–Sheldon syndrome, and in DA2B, Sheldon–Hall
syndrome [18]. Further, a mutation in fetal myosin heavy
chain (MYH8) has been described in DA7, trismus-pseu-
docamptodactyly syndrome [19]. A defective function of
contractile muscle proteins during fetal life influencing
fetal mobility seems to be the common cause of congenital
joint contractures in these syndromes [18, 19].
DA2A, Freeman–Sheldon syndrome, and DA2B, Shel-
don–Hall syndrome, have been reported as the first disor-
ders associated with mutations in embryonic MyHC
(MYH3) [18]. DA syndromes are associated with missense
mutations in various genes coding for sarcomeric proteins.
The genes thus far demonstrated to be involved in DA
syndromes are TNNI2 (troponin I), TPM2 (b-tropomyosin)
[17], TNNT3 (troponin T) [20], MYH8 (perinatal MyHC),
and MYH3 (embryonic MyHC) [18].
These findings indicate that DA syndromes are caused
by myopathies with onset during fetal development, but
few studies have involved analysis of muscle tissue in these
diseases.
Swedish arthrogryposis study
In a nationwide study of arthrogryposis in children and
adolescents in Sweden, 131 individuals were investigated
[43]. Ages ranged from newborn to 28 years of age, with a
mean age of 8.25 years. There were 59 females and 72
males. The majority of included individuals were under
20 years of age at the time of investigation.
Amyoplasia was diagnosed in 48 (37 %) patients; DA
was found in 27 (21 %) index patients; 22 (17 %) children
were found to have arthrogryposis with CNS involvement.
Six children had clinical signs of myopathy; different
genetic syndromes were identified or suspected in ten
children (Larsen syndrome, Turner syndrome, facio-audio-
symphalangism syndrome Sprenger syndrome), six chil-
dren had arthrogryposis in the lower extremities only, two
of these with vertebral anomalies and caudal regression
syndrome, and a further 12 children had arthrogryposis that
we could not specify further.
Thirty-five patients with amyoplasia were studied sep-
arately [44]. Involvement of only the upper limbs was seen
in four, only the lower limbs in six, and both the upper and
lower limbs in 25 patients.
Strong correlations were found between muscle strength
and motor function, and only moderate correlations
between ROM and motor function.
Families with DA were also studied separately.
In one three-generation family with DA1 and a mutation
in TNNI2, myopathy due to sarcomeric protein dysfunction
was found to be the probable underlying cause [45].
In a mother and daughter with DA2B, muscle weakness
associated with a TPM2 mutation was found [46], and in
patients from three families with MYH3 mutations, devel-
opmental myosin myopathy with persistence postnatally
was demonstrated [47].
Clinical and genetic findings in affected individuals with
DA from 21 families were investigated, index cases and
affected relatives [48].
A classification of the investigated patients with
arthrogryposis into different specific diagnoses identified
the three largest groups, in decreasing order, as amyoplasia,
DA syndromes, and arthrogryposis with CNS involvement.
As a group, patients with amyoplasia have more severe
muscle weakness and joint contractures than DA patients.
Consequently, motor function is more compromised in
amyoplasia. In DA syndromes, DA2A is more severe than
DA2B, and DA1 is milder than DA2B.
In amyoplasia, muscle function is more important than
severity of joint contractures for the prediction of walking
ability and functional level. Joint position at birth is also of
importance, especially for the prediction of ambulatory
function. More attention should be paid to development of
muscle strength with early stimulation of active move-
ments. Immobilization should be minimized.
In DA1, 2A and 2B pathogenic mutations were found in
TNNI2, TPM2, and MYH3. Troponin, tropomyosin, and
myosin are sarcomeric proteins important for muscle con-
traction. These DA syndromes are caused by fetal
myopathy due to sarcomeric protein dysfunction causing
muscle weakness and secondary joint contractures.
DA1 and 2B are clinically and genetically heterogenous
conditions. Mutations in the same gene were found in
different DA syndromes, suggesting varying clinical pen-
etrance and expression, rather than separate genetic syn-
dromes. Different gene mutations were found in the same
clinical syndrome, suggesting multiple gene background.
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A pathogenic mutation is found more often in familial
than in sporadically occurring cases, but de novo mutations
are not uncommon.
DA syndromes may be re-defined according to patho-
genic background, as several DA syndromes have been
found to be caused by sarcomeric myopathy.
In studying the treatment of arthrogryposis, the main
conclusions were that a careful clinical evaluation by a
team with experience in arthrogryposis as early as possible
is important for correct diagnosis and planning of treat-
ment, and that care should be taken to minimize immobi-
lization in order to avoid further muscle atrophy, especially
during early life.
The majority of cases investigated in the study did not
have a specific diagnosis other than arthrogryposis at the
time of investigation. In some cases, further medical
investigations such as muscle biopsy or radiology investi-
gations were needed to clarify the diagnosis, but in many
cases, careful clinical evaluation by professionals with
experience in the evaluation of children with arthrogrypo-
sis was sufficient. Both in amyoplasia and in DA syn-
dromes, diagnosis is based on clinical evaluation. An
evaluation by a clinical geneticist is also invaluable in a
number of cases, mainly those with specific malformation
syndromes or dysmorphic features. A multidisciplinary
evaluation by an experienced arthrogryposis team is nee-
ded for a correct diagnosis in the majority of cases.
In conclusion:
• A correct diagnosis is important.
• Early physical therapy, stretching of joint and muscle
contractures, is important. The first 3–4 months of life
are especially rewarding.
• Promote active muscle use—avoid immobilization.
• Functional assessment before surgery is important.
• Take care of pain management, avoid painful
procedures.
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